This article analyzes to what extent the obstacles or difficulties to access to medicines not in\u00adcluded in the pharmaceutical provision of the National Health System have constitutional significance. It concludes that in this field there is a lack of legal certainty and a deficient publicity of the applicable rules which is hardly compatible with the requirements of art. 9.3 of the Constitution. That access to nonreim\u00adbursed medicinal products is unequal from a territorial point of view, with situations of inequity that are difficult to reconcile with art. 14 of the Spanish Constitution (CE). And that denying access to a medicinal product can be considered contrary to the right to life (art. 15 CE) and to the protection of health (art. 43 CE) whenever there is a serious, certain and immediate danger to the patient’s health.<\/p>\n","protected":false},"excerpt":{"rendered":"
This article analyzes to what extent the obstacles or difficulties to access to medicines not in\u00adcluded in the pharmaceutical provision of the National Health System have constitutional significance. It concludes that in this field there is a lack of legal certainty and a deficient publicity of the applicable rules which is hardly compatible with the… <\/p>\n